Search

Your search keyword '"Drory, VE"' showing total 121 results

Search Constraints

Start Over You searched for: Author "Drory, VE" Remove constraint Author: "Drory, VE"
121 results on '"Drory, VE"'

Search Results

1. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

2. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

3. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

4. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

5. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

6. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

7. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

14. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

15. Changes in saccadic intrusions over time as an objective biomarker to follow ALS disease progression.

16. Quantitative sonographic assessment of muscle thickness and fasciculations distribution is a sensitive tool for neuromuscular disorders.

17. Pre-morbid Laboratory Tests, Diseases, and Medications in Amyotrophic Lateral Sclerosis in Israel.

18. The Sensitivity of Quantitative Sonographic Assessment of Muscle Thickness for Amyotrophic Lateral Sclerosis Diagnosis.

19. Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial.

20. Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS.

21. The Sensitivity and Specificity of Split-Hand Index Using Muscle Sonography.

22. FUS-P525L Juvenile Amyotrophic Lateral Sclerosis and Intellectual Disability: Evidence for Association and Oligogenic Inheritance.

23. Common genetic basis of ALS patients and soccer players may contribute to disease risk.

24. Longer-term follow-up of nusinersen efficacy and safety in adult patients with spinal muscular atrophy types 2 and 3.

25. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis.

26. Fasciculation frequency at the biceps brachii and brachialis muscles is associated with amyotrophic lateral sclerosis disease burden and activity.

27. Split-hand phenomenon in motor neuron diseases: Sonographic assesment of muscle thickness.

28. Superiority of sonographic evaluation of contracted versus relaxed muscle thickness in motor neuron diseases.

29. A novel mutation in TARDBP segregates with amyotrophic lateral sclerosis in a large family with early onset and fast progression.

30. Quantitative sonographic evaluation of muscle thickness and fasciculation prevalence in healthy subjects.

31. Muscle thickness measured by ultrasound is reduced in neuromuscular disorders and correlates with clinical and electrophysiological findings.

32. Rare homozygosity in amyotrophic lateral sclerosis suggests the contribution of recessive variants to disease genetics.

33. Early post-marketing experience with edaravone in an unselected group of patients with ALS.

34. A tri-modal distribution of age-of-onset in female patients with myasthenia gravis is associated with the gender-related clinical differences.

35. Diagnostic criteria for amyotrophic lateral sclerosis: A multicentre study of inter-rater variation and sensitivity.

36. "ALS reversals": demographics, disease characteristics, treatments, and co-morbidities.

37. High frequency of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis patients from two founder populations sharing the same risk haplotype.

38. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

39. Reconsidering the causality of TIA1 mutations in ALS.

40. Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel.

41. Thymus involvement in myasthenia gravis: Epidemiological and clinical impacts of different self-tolerance breakdown mechanisms.

42. Characterization of patients with ocular myasthenia gravis - A case series.

43. OPTN 691_692insAG is a founder mutation causing recessive ALS and increased risk in heterozygotes.

44. Wet, volatile, and dry biomarkers of exercise-induced muscle fatigue.

45. Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis.

47. Dynamic MRI testing of the cervical spine has prognostic significance in patients with progressive upper-limb distal weakness and atrophy.

48. Listening to music during electromyography does not influence the examinee's anxiety and pain levels.

49. Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis.

50. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis.

Catalog

Books, media, physical & digital resources